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Hydrogenated	 amorphous	 silicon	 colloids	 of	 low	 surface	 area	 (	 <5m2/g)	 are	
shown	 to	 exhibit	 complete	 in-vitro	biodegradation	 into	 orthosilicic	 acid	within	
10-15	days	at	37°C.	When	converted	into	polycrystalline	silicon	colloids,	by	high	
temperature	 annealing	 in	 an	 inert	 atmosphere,	 microparticle	 solubility	 is	
dramatically	 reduced.	 	 The	 data	 suggests	 that	 amorphous	 silicon	 does	 not	
require	 nanoscale	 porosification	 for	 full	 in-vivo	 biodegradability.	 This	 has	
significant	implications	for	using	a-Si:H	coatings	for	medical	implants	in	general,	
and	orthopaedic	implants	in	particular.	The	high	sphericity	and	biodegradability	








The	 biocompatibility	 of	 various	 nanostructures	 of	 the	 semiconductor	 silicon	 is	
receiving	increasing	attention	for	drug	delivery,	medical	imaging	and	biosensing	
[1-3].	The	in-vitro	biodegradability	of	nanostructured	porous	forms	of	very	high	
surface	 area	 was	 first	 revealed	 in	 the	 1990’s	 and	 its	 use	 for	 medical	 imaging	
purposes	has	been	demonstrated	 in-vivo[4,5].	Mesoporous	silicon	 is	 commonly	
derived	 by	 etching	 single	 crystal	 or	 polycrystalline	 wafers	 and	 powders	 and	
largely	 retains	 the	 crystallinity	 of	 such	 feedstocks	 [6].	 Micromachined	 silicon,		
macroporous	 and	 large	 grain	 size	 polycrystalline	 silicon	microparticles	 do	 not	
exhibit	 significant	 biodegradability,	 in-vitro	 nor	 in-vivo[7,8].	 Chemical	 Vapor	
Deposition	 techniques	 (CVD)	allow	 the	 formation	of	polydisperse	 silicon	micro	
and	nanoparticles,	with	size	ranging	from	0.5	to	5	micrometers,	and	with	a	highly	
spherical	shape	[9].	The	combined	low	surface	roughness,	spherical	topology	and		
high	 refractive	 index,	 results	 in	 silicon	 “colloids”	 or	 microsphere	 assemblies	
working	 very	 well	 as	 optical	 microcavities	 in	 the	 IR	 region	 [10].	 They	 can	 be	
porous,	 amorphous	 or	 polycrystalline,	 depending	 on	 the	 decomposition	
parameters	 [11].	 Silicon	 colloids	 can	 be	 seen	 as	 a	 new	 enabling	 particulate	
system	 with	 many	 applications	 in	 materials	 science,	 photonics,	 cosmetics	 and	
sensing	 [9,10,12,13,14].	 Here	 we	 report	 on	 the	 in-vitro	 biodegradability	 of	
nanostructured	amorphous	and	polycrystalline	silicon	colloids.	Our	data	shows	




Silicon	 colloids	 for	 biodegradability	 assays	 were	 fabricated	 by	 the	 method	
described	 elsewhere	 [9].	 Amorphous	 silicon	 colloids	 were	 obtained	 by	
decomposing	disilane	at	450°C	in	a	CVD	reactor.	Polycrystalline	silicon	colloids	
were	 achieved	by	 annealing	 the	 amorphous	 colloids	 at	 800°C	 for	 1	 hour	 in	 an	
argon	 inert	 atmosphere.	 Structural	 properties	 of	 the	 colloids	 were	 studied	 by	
using	 several	 techniques,	 namely	 Scanning	 Electron	 Microscopy	 (SEM),	 X	 Ray	
Powder	Diffraction	 (XRD)	and	Raman	Spectroscopy	 (RS).	The	 samples	 for	XRD	
analysis	 consist	 of	 big	 clusters,	 of	 100	micrometers	 in	 height	 by	1	 cm2	 in	 area	
approximately,	 containing	many	microspheres,	which	were	 deposited	 on	 silica	
substrates.	We	used	an	X-ray	wavelength,	λ	=	1.54187	Å,	and	the	spot	size	was	
about	 4	 mm	 diameter,	 therefore	 the	 obtained	 X-ray	 spectra	 correspond	 to	 an	
average	 signal	 produced	 by	 millions	 of	 microspheres.	 The	 samples	 for	 (RS)	
consist	 of	 isolated	 microspheres	 on	 silica	 substrates.	 Raman	 spectra	 were	
measured	 on	 single	 microspheres	 by	 using	 a	 Jobin-Ivon	 T64000	 triple	
monocromator	provided	with	 a	microprobe	accessory	 and	pumped	with	 an	Ar	
ion	laser.	The	excitation	wavelength	was	545	nm,	beam	power	of	10µW	and	spot	
size	of	10	µm,	corresponding	to	a	very	low	Micro-Raman	excitation	density	of	10	










50rpm	 in	 a	 water	 bath	 for	 periods	 up	 to	 10	 days.	 Aliquots	 of	 2.5ml	 were	
withdrawn	 for	 analysis	 at	 predetermined	 time	 points.	 These	 were	 acidified,	
reacted	with	1%	disodium	EDTA,	then	5%	ammonium	molybdate	and	then	17%	
sodium	 sulphite	 solution.	 Their	 resulting	 absorbance	 at	 700nm	 was	 then	




Figure	 1	 shows	 the	 highly	 spherical	 nature	 of	 the	microparticles.	 The	 colloids	






amorphous	 microparticle	 colloid	 possesses	 minimal	 microporosity	 and	
mesoporosity.	Indeed	optical	scattering	from	single	particles	is	sensitive	to	both	
chemical	 composition	 and	 porosity	 with	 hollow	 particles	 having	 completely	

























Figure 5.1: Silcon microspheres obtained by CVD process. The surface of
the spheres appear very smooth when analyzing with SEM.
Figure 5.2: Sphere surface analyzed by AFM. The diagonal ridges is an







silicon	 colloids.	 Trace	 (c)	 corresponds	 to	 a	 reference	 sample	 made	 of	 single	
crystal	silicon	powder.	The	amorphous	nature	of	the	colloids,	that	were	grown	at	
450°C,	can	be	deduced	from	the	wide	feature	of	trace	(a).	Trace	(b)	confirms	that	





















The	 application	 of	 the	 Scherrer	 equation	 to	 the	 peak	 centered	 around	 2ϕ=28°	
gives	a	crystallite	size	of	about	30	nm	[17].	This	transformation	can	also	be	seen	
through	micro-Raman	analysis,	as	it	is	illustrated	by	the	spectra	(a),	(b)	and	(c)	
of	 Figure	 3,	 that	 correspond	 to	 amorphous,	 polycrystalline	 and	 the	 reference	

























reference	 crystalline	 silicon	 sample	 (c),	 is	 in	 good	 agreement	 with	 the	 small	


































We	 believe	 this	 is	 the	 first	 time	 that	 the	 biodegradability	 of	 amorphous	
semiconducting	 silicon	 has	 been	 quantitatively	 assessed.	 Biodegradation	 of	
silicon	nanostructures	has	been	monitored	ex-situ	by	electron	microscopy	of	the	














The	 oxidative	 first	 step	 generates	 hydrogen	 gas	 and	 is	 dependent	 on	 both	
electronic	band	gap	and	doping	of	the	semiconductor.	Complete	hydrolysis	of	the	
oxide	 phase	 then	 generates	 orthosilicic	 acid,	 which	 is	 the	 natural	 bioavailable	





noted	 that	 layers	 which	 were	 virtually	 amorphous	 underwent	 significant	
corrosion	in	simulated	human	plasma,	but	the	etch	rate	was	not	quantified	[18].	




solubility	 of	 the	 amorphous	 phase	 in	 water	 is	 approximately	 10	 times	 higher	
than	 that	 of	 crystalline	 quartz	 [19].	 Quartz	 is	 very	 resistant	 to	 hydrolysis	 and	
does	not	biodegrade	in	physiological	environments.	Certain	forms	of	high	surface	
area,	amorphous	mesoporous	silica	however	does	show	biodegradability	whilst	
others	 show	 high	 stability	 against	 hydrolysis	 [20,	 21].	 It	 seems	 likely	 that	
amorphous	 silicon	 in	 various	 structural	 forms	 will	 show	 much	 faster	
biodegradation	 kinetics	 to	 those	 of	 both	 amorphous	 silica	 and	 polycrystalline	
silicon.	 This	 has	 encouraging	 implications	 for	 the	 use	 of	 amorphous	 silicon	
coatings	 in	medical	 implant	 applications	where	 a	 temporary	 structure	 conveys	
advantages	 in	 device	 efficacy	 and	 biocompatibility	 regarding	 its	 intended	 use.	
The	 observation	 of	 its	 full	 biodegradability	 without	 porosification	will	 expand	
the	 fabrication	 options	 in	 this	 regard.	 Mesoporosity	 is	 a	 major	 attribute	 for	
applications	such	as	drug	delivery	but	 there	are	numerous	uses	 in	orthopedics	
and	orthopedic	tissue	engineering	where	controlled	silicic	acid	release	is	used	to	
stimulate	 bone	 growth	 [1,2,22].	 Fully	 biodegradable	 spheres	 of	 submicron	
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